Eur J Endocrinol 143: 639-647 Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, et al
Less Common or Severe Side Effects While rare, other treatment-emergent adverse events have been observed: Vomiting, particularly in patients prone to gastrointestinal sensitivity Dizziness or a strange feeling shortly after administration Darkening of skin or gums, attributed to the peptides melanocortin action Mild allergic reaction (e.g., itching, rash, or swelling) These adverse events are more likely to occur in patients who are highly sensitive to neuropeptides or who have pre-existing health conditions affecting metabolism or vascular response
Mod Pathol 28 , 391402 (2015)
Comparamos a las personas que comenzaron a tomar medicamentos GLP-1 con las que no lo hicieron, ajustando las diferencias en el historial mdico, la demografa y otros factores